Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Beretta

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|March 19, 2008
Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compoundsValentina Benedetti, Paola Perego, Giovanni Luca Beretta, et al.
European Journal of Medicinal Chemistry|March 23, 2013
Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agentsRaffaella Cincinelli, Loana Musso, Sabrina Dallavalle, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2008
E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluationGiuseppe Giannini, Mauro Marzi, Walter Cabri, et al.
Molecules (Basel, Switzerland)|January 19, 2020
Design of Disruptors of the Hsp90-Cdc37 InterfaceIlda D'Annessa, Naama Hurwitz, Valentina Pirota, et al.
Journal of Medicinal Chemistry|June 18, 2009
Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecinsCristian Samorì, Andrea Guerrini, Greta Varchi, et al.
Biochemical Pharmacology|December 16, 2006
Preclinical efficacy of ST1976, a novel camptothecin analog of the 7-oxyiminomethyl seriesMichelandrea De Cesare, Giovanni Luca Beretta, Stella Tinelli, et al.
Alzheimer'S Research & Therapy|February 25, 2019
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteriaSilvia Paola Caminiti, Arianna Sala, Leonardo Iaccarino, et al.
Cancers|June 2, 2021
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug CombinationsSerena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, et al.
Bioconjugate Chemistry|October 9, 2008
The role of polyamine architecture on the pharmacological activity of open lactone camptothecin-polyamine conjugatesCristian Samorì, Cristian Samor, Andrea Guerrini, et al.
Cancer Letters|March 10, 2017
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axisRihan El Bezawy, Denis Cominetti, Nicola Fenderico, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|March 19, 2008
Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compoundsValentina Benedetti, Paola Perego, Giovanni Luca Beretta, et al.
European Journal of Medicinal Chemistry|March 23, 2013
Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agentsRaffaella Cincinelli, Loana Musso, Sabrina Dallavalle, et al.
Bioorganic & Medicinal Chemistry Letters|April 22, 2008
E-ring-modified 7-oxyiminomethyl camptothecins: Synthesis and preliminary in vitro and in vivo biological evaluationGiuseppe Giannini, Mauro Marzi, Walter Cabri, et al.
Molecules (Basel, Switzerland)|January 19, 2020
Design of Disruptors of the Hsp90-Cdc37 InterfaceIlda D'Annessa, Naama Hurwitz, Valentina Pirota, et al.
Journal of Medicinal Chemistry|June 18, 2009
Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecinsCristian Samorì, Andrea Guerrini, Greta Varchi, et al.
Biochemical Pharmacology|December 16, 2006
Preclinical efficacy of ST1976, a novel camptothecin analog of the 7-oxyiminomethyl seriesMichelandrea De Cesare, Giovanni Luca Beretta, Stella Tinelli, et al.
Alzheimer'S Research & Therapy|February 25, 2019
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteriaSilvia Paola Caminiti, Arianna Sala, Leonardo Iaccarino, et al.
Cancers|June 2, 2021
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug CombinationsSerena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, et al.
Bioconjugate Chemistry|October 9, 2008
The role of polyamine architecture on the pharmacological activity of open lactone camptothecin-polyamine conjugatesCristian Samorì, Cristian Samor, Andrea Guerrini, et al.
Cancer Letters|March 10, 2017
miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axisRihan El Bezawy, Denis Cominetti, Nicola Fenderico, et al.
Pageof 6